Skip to main content
Top
Published in: Journal of Cardiothoracic Surgery 1/2013

Open Access 01-12-2013 | Research article

Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery

Authors: Hua Liu, Chunsheng Wang, Lan Liu, Yamin Zhuang, Xiaomei Yang, Ying Zhang

Published in: Journal of Cardiothoracic Surgery | Issue 1/2013

Login to get access

Abstract

Background

The purpose of the research was to find out the factors which influence plasma N-terminal pro-brain natriuretic peptide (NT-proBNP) levels, then to assess whether preoperative plasma NT-proBNP levels could predict postoperative outcomes of cardiac surgery.

Methods

Between November 2008 and February 2010,225 patients who underwent cardiac surgery in our department were included in the study. The mean age was 61.25 ± 12.54 years, and 156 (69.3%) patients were male. NT-proBNP, CK-MB, cTnT and creatinine levels were measured preoperatively and 24 hours after operation. Postoperatively outcomes including ventilation time, length of stay in ICU and hospital, and mortality were closely monitored. The endpoints includes: 1) use of inotropic agents or intra-aortic balloon pump ≥24 h; 2) creatinine level elevated to hemodialysis; 3) cardiac events; 4) ICU stay ≥5d; 5) ventilation dependence ≥ 72 h; 6) deaths within 30 days of surgery.

Results

NT-proBNP concentrations (median [interquartile range]) increased from 728.4 pg/ml (IQR 213.5 to 2551 pg/ml) preoperatively to 1940.5 pg/ml (IQR 995.9 to 3892 pg/ml) postoperatively (P = 0.015). Preoperative atrial fibrillation, NYHA class III/IV, ejection fraction, pulmonary arterial pressure, left ventricle end-diastolic diameter (LVEDD), preoperative plasma creatinine and cTnT levels were significantly associated with preoperative NT-proBNP levels in univariate analysis. The preoperative NT-proBNP was closely related to ventilation time (P = 0.009), length of stay in ICU (P = 0.004) and length of stay in hospital (P = 0.019). Receiver operating characteristic curves demonstrated a cut-off value above 2773.5 pg/ml was the best cutoff (sensitivity of 63.6% and specificity of 80.8%) to predict the mortality within 30d of surgery.

Conclusions

Preoperative plasma NT-proBNP level presents a high individual variability in patients undergoing cardiac surgery. NYHA classification, ejection fraction, pulmonary arterial pressure, LVEDD, atrial fibrillation, preoperative plasma creatinine, and cTnT levels are significantly associated with preoperative NT-proBNP levels. Preoperative NT-proBNP is a valuable marker in predicting postoperative outcomes.
Appendix
Available only for authorised users
Literature
1.
go back to reference Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994, 90: 195-203. 10.1161/01.CIR.90.1.195.CrossRefPubMed Yasue H, Yoshimura M, Sumida H, Kikuta K, Kugiyama K, Jougasaki M, Ogawa H, Okumura K, Mukoyama M, Nakao K: Localization and mechanism of secretion of B-type natriuretic peptide in comparison with those of A-type natriuretic peptide in normal subjects and patients with heart failure. Circulation. 1994, 90: 195-203. 10.1161/01.CIR.90.1.195.CrossRefPubMed
2.
go back to reference Houben AJ, van der Zander K, de Leeuw PW: Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005, 19: 411-419. 10.1111/j.1472-8206.2005.00336.x.CrossRefPubMed Houben AJ, van der Zander K, de Leeuw PW: Vascular and renal actions of brain natriuretic peptide in man: physiology and pharmacology. Fundam Clin Pharmacol. 2005, 19: 411-419. 10.1111/j.1472-8206.2005.00336.x.CrossRefPubMed
3.
go back to reference Steiner J, Guglin M: BNP or NTproBNP? A clinician’s perspective. Int J Cardiol. 2008, 129: 5-14. 10.1016/j.ijcard.2007.12.093.CrossRefPubMed Steiner J, Guglin M: BNP or NTproBNP? A clinician’s perspective. Int J Cardiol. 2008, 129: 5-14. 10.1016/j.ijcard.2007.12.093.CrossRefPubMed
4.
go back to reference Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M: Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med. 2006, 44: 366-378.CrossRefPubMed Clerico A, Carlo Zucchelli G, Pilo A, Passino C, Emdin M: Clinical relevance of biological variation: the lesson of brain natriuretic peptide (BNP) and NT-proBNP assay. Clin Chem Lab Med. 2006, 44: 366-378.CrossRefPubMed
5.
go back to reference Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN: on behalf of the Val-HeFT Investigators. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a larger population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure data. Clin Chem. 2006, 52: 1528-1538. 10.1373/clinchem.2006.069575.CrossRefPubMed Masson S, Latini R, Anand IS, Vago T, Angelici L, Barlera S, Missov ED, Clerico A, Tognoni G, Cohn JN: on behalf of the Val-HeFT Investigators. Direct comparison of B-type natriuretic peptide (BNP) and amino-terminal proBNP in a larger population of patients with chronic and symptomatic heart failure: the Valsartan Heart Failure data. Clin Chem. 2006, 52: 1528-1538. 10.1373/clinchem.2006.069575.CrossRefPubMed
6.
go back to reference Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol. 2007, 50: 2357-68. 10.1016/j.jacc.2007.09.021.CrossRefPubMed Daniels LB, Maisel AS: Natriuretic peptides. J Am Coll Cardiol. 2007, 50: 2357-68. 10.1016/j.jacc.2007.09.021.CrossRefPubMed
7.
go back to reference Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J: Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006, 34: 995-1000. 10.1097/01.CCM.0000206110.94385.C4.CrossRefPubMed Provenchère S, Berroeta C, Reynaud C, Baron G, Poirier I, Desmonts JM, Iung B, Dehoux M, Philip I, Bénessiano J: Plasma brain natriuretic peptide and cardiac troponin I concentrations after adult cardiac surgery: association with postoperative cardiac dysfunction and 1-year mortality. Crit Care Med. 2006, 34: 995-1000. 10.1097/01.CCM.0000206110.94385.C4.CrossRefPubMed
8.
go back to reference Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F: The influence of age, sex and other variables on the plasma level of N- terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 2003, 89: 745-751. 10.1136/heart.89.7.745.CrossRefPubMedPubMedCentral Raymond I, Groenning BA, Hildebrandt PR, Nilsson JC, Baumann M, Trawinski J, Pedersen F: The influence of age, sex and other variables on the plasma level of N- terminal pro brain natriuretic peptide in a large sample of the general population. Heart. 2003, 89: 745-751. 10.1136/heart.89.7.745.CrossRefPubMedPubMedCentral
9.
go back to reference Rossi A, Enriquez-Sarano M, Burneet JC, Lerman A, Abel MD, Seward JB: Natriuretic peptide levels in atrial fibrillation. J Am Coll Cardiol. 2000, 35: 1256-1262. 10.1016/S0735-1097(00)00515-5.CrossRefPubMed Rossi A, Enriquez-Sarano M, Burneet JC, Lerman A, Abel MD, Seward JB: Natriuretic peptide levels in atrial fibrillation. J Am Coll Cardiol. 2000, 35: 1256-1262. 10.1016/S0735-1097(00)00515-5.CrossRefPubMed
10.
go back to reference Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA: Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta. 2001, 303: 127-132. 10.1016/S0009-8981(00)00393-4.CrossRefPubMed Avidan MS, Meehan N, Ponte J, El-Gamel A, Sherwood RA: Changes in brain natriuretic peptide concentrations following open cardiac surgery with cardioplegic cardiac arrest. Clin Chim Acta. 2001, 303: 127-132. 10.1016/S0009-8981(00)00393-4.CrossRefPubMed
11.
go back to reference Morimoto K, Mori T, Ishiguro S, Matsuda N, Hara Y, Kuroda H: Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today. 1998, 28: 23-29. 10.1007/BF02483604.CrossRefPubMed Morimoto K, Mori T, Ishiguro S, Matsuda N, Hara Y, Kuroda H: Perioperative changes in plasma brain natriuretic peptide concentrations in patients undergoing cardiac surgery. Surg Today. 1998, 28: 23-29. 10.1007/BF02483604.CrossRefPubMed
12.
go back to reference Nozohoor S, Nilsson J, Lührs C, Roijer A, Algotsson L, Sjögren J: B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth. 2009, 23: 161-165. 10.1053/j.jvca.2008.11.006.CrossRefPubMed Nozohoor S, Nilsson J, Lührs C, Roijer A, Algotsson L, Sjögren J: B-type natriuretic peptide as a predictor of postoperative heart failure after aortic valve replacement. J Cardiothorac Vasc Anesth. 2009, 23: 161-165. 10.1053/j.jvca.2008.11.006.CrossRefPubMed
13.
go back to reference Attaran S, Sherwood R, Desai J, Langworthy R, Mhandu P, John L, El-Gamel A: Brain natriuretic peptide a predictive marker in cardiac surgery. Interact CardioVasc Thorac Surg. 2009, 9: 662-666. 10.1510/icvts.2008.189837.CrossRefPubMed Attaran S, Sherwood R, Desai J, Langworthy R, Mhandu P, John L, El-Gamel A: Brain natriuretic peptide a predictive marker in cardiac surgery. Interact CardioVasc Thorac Surg. 2009, 9: 662-666. 10.1510/icvts.2008.189837.CrossRefPubMed
14.
go back to reference Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004, 43: 1873-1879. 10.1016/j.jacc.2003.12.048.CrossRefPubMed Hutfless R, Kazanegra R, Madani M, Bhalla MA, Tulua-Tata A, Chen A, Clopton P, James C, Chiu A, Maisel AS: Utility of B-type natriuretic peptide in predicting postoperative complications and outcomes in patients undergoing heart surgery. J Am Coll Cardiol. 2004, 43: 1873-1879. 10.1016/j.jacc.2003.12.048.CrossRefPubMed
15.
go back to reference Sodeck G, Domanovits H, Schillinger M, Janata K, Thalmann M, Ehrlich MP, Endler G, Laggner A: Pre-operative N-Terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol. 2008, 51: 1092-1097. 10.1016/j.jacc.2007.12.015.CrossRefPubMed Sodeck G, Domanovits H, Schillinger M, Janata K, Thalmann M, Ehrlich MP, Endler G, Laggner A: Pre-operative N-Terminal pro-brain natriuretic peptide predicts outcome in type A aortic dissection. J Am Coll Cardiol. 2008, 51: 1092-1097. 10.1016/j.jacc.2007.12.015.CrossRefPubMed
16.
go back to reference Crescenzi G, Landoni G, Bignami E, Belloni I, Biselli C, Rosica C, Guarracino F, Marino G, Zanqrillo A: N-terminal B- natriuretic peptide after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2009, 23: 147-150. 10.1053/j.jvca.2008.10.002.CrossRefPubMed Crescenzi G, Landoni G, Bignami E, Belloni I, Biselli C, Rosica C, Guarracino F, Marino G, Zanqrillo A: N-terminal B- natriuretic peptide after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2009, 23: 147-150. 10.1053/j.jvca.2008.10.002.CrossRefPubMed
Metadata
Title
Perioperative application of N-terminal pro-brain natriuretic peptide in patients undergoing cardiac surgery
Authors
Hua Liu
Chunsheng Wang
Lan Liu
Yamin Zhuang
Xiaomei Yang
Ying Zhang
Publication date
01-12-2013
Publisher
BioMed Central
Published in
Journal of Cardiothoracic Surgery / Issue 1/2013
Electronic ISSN: 1749-8090
DOI
https://doi.org/10.1186/1749-8090-8-1

Other articles of this Issue 1/2013

Journal of Cardiothoracic Surgery 1/2013 Go to the issue